IL134363A0 - Method for treating disease-related or drug-induced dyskinesias - Google Patents

Method for treating disease-related or drug-induced dyskinesias

Info

Publication number
IL134363A0
IL134363A0 IL13436398A IL13436398A IL134363A0 IL 134363 A0 IL134363 A0 IL 134363A0 IL 13436398 A IL13436398 A IL 13436398A IL 13436398 A IL13436398 A IL 13436398A IL 134363 A0 IL134363 A0 IL 134363A0
Authority
IL
Israel
Prior art keywords
drug
treating disease
induced dyskinesias
dyskinesias
induced
Prior art date
Application number
IL13436398A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL134363A0 publication Critical patent/IL134363A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13436398A 1997-10-24 1998-09-16 Method for treating disease-related or drug-induced dyskinesias IL134363A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6315697P 1997-10-24 1997-10-24
PCT/US1998/019357 WO1999021539A1 (en) 1997-10-24 1998-09-16 Method for treating disease-related or drug-induced dyskinesias

Publications (1)

Publication Number Publication Date
IL134363A0 true IL134363A0 (en) 2001-04-30

Family

ID=22047302

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13436398A IL134363A0 (en) 1997-10-24 1998-09-16 Method for treating disease-related or drug-induced dyskinesias

Country Status (15)

Country Link
US (1) US6284776B1 (hu)
EP (1) EP1024799A1 (hu)
JP (1) JP2001520988A (hu)
KR (1) KR20010024548A (hu)
AU (1) AU760800B2 (hu)
BR (1) BR9814867A (hu)
CA (1) CA2299400C (hu)
HU (1) HUP0004900A3 (hu)
IL (1) IL134363A0 (hu)
IS (1) IS5384A (hu)
NO (1) NO20001893L (hu)
NZ (1) NZ502785A (hu)
PL (1) PL340080A1 (hu)
WO (1) WO1999021539A1 (hu)
ZA (1) ZA989693B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー　ユニバーシティ ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
CA2381630A1 (en) * 2001-04-23 2002-10-23 Leonard Theodore Meltzer Method for preventing dyskinesias
ES2312603T3 (es) 2001-07-24 2009-03-01 Richter Gedeon Nyrt Derivados de piperidina como antagonistas del receptor nmda.
US7160913B2 (en) * 2002-09-13 2007-01-09 Thomas Jefferson University Methods and kit for treating Parkinson's disease
MXPA06004038A (es) * 2003-10-08 2006-06-28 Pfizer Compuestos de 1-'2-(4-hidroxifenil)-2-hidroxietil-piperidin-4-ol como antagonsitas del receptor n-metil-d-aspartato.
NZ582917A (en) * 2007-06-29 2013-01-25 Univ Emory Nmda receptor antagonists for neuroprotection
US8951968B2 (en) 2009-10-05 2015-02-10 Northwestern University Methods of treating depression and other related diseases
SG10201800159QA (en) 2011-11-22 2018-02-27 Univ California Cysteamine and/or cystamine for treating ischemic injury
US10752588B2 (en) 2014-12-19 2020-08-25 The Broad Institute, Inc. Dopamine D2 receptor ligands
US10633336B2 (en) 2014-12-19 2020-04-28 The Broad Institute, Inc. Dopamine D2 receptor ligands

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5733M (hu) 1966-09-27 1968-01-22
US5272160A (en) 1989-05-17 1993-12-21 Pfizer Inc 2-piperidino-1-alkanol derivatives as antiischemic agents
EP0497843A4 (en) * 1989-10-27 1992-09-23 The Du Pont Merck Pharmaceutical Company (n-phthalimidoalkyl) piperidines
US5356906A (en) * 1989-10-27 1994-10-18 The Du Pont Merck Pharmaceutical Company (N-phthalimidoalkyl) piperidines useful as treatments for psychosis
US5116846A (en) * 1990-03-28 1992-05-26 Du Pont Merck Pharmaceutical Company N-aralkyl piperidine derivatives as psychotropic drugs
EP0591426A4 (en) * 1991-06-27 1996-08-21 Univ Virginia Commonwealth Sigma receptor ligands and the use thereof
US5364867A (en) * 1992-11-30 1994-11-15 Sterling Winthrop Inc. 4-phenylpiperdine agents for treating cns disorders
TW281670B (hu) 1993-09-02 1996-07-21 Hoffmann La Roche
FR2717080B1 (fr) 1994-03-09 1996-12-13 Synthelabo Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales.
FR2717810B1 (fr) * 1994-03-22 1996-04-26 Adir Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP0828513B1 (en) * 1995-05-26 2004-01-21 Pfizer Inc. Combinations for the treatment of parkinsonism containing selective nmda antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists

Also Published As

Publication number Publication date
AU760800B2 (en) 2003-05-22
AU9318198A (en) 1999-05-17
HUP0004900A2 (hu) 2001-06-28
KR20010024548A (ko) 2001-03-26
NZ502785A (en) 2003-03-28
US6284776B1 (en) 2001-09-04
PL340080A1 (en) 2001-01-15
JP2001520988A (ja) 2001-11-06
HUP0004900A3 (en) 2002-03-28
ZA989693B (en) 1999-04-29
EP1024799A1 (en) 2000-08-09
NO20001893D0 (no) 2000-04-12
CA2299400A1 (en) 1999-05-06
BR9814867A (pt) 2000-10-03
NO20001893L (no) 2000-04-12
CA2299400C (en) 2004-04-27
WO1999021539A1 (en) 1999-05-06
IS5384A (is) 2000-02-25

Similar Documents

Publication Publication Date Title
ZA9885B (en) Projectile and method for producing it
AU6589798A (en) Ileus treatment method
AU9423798A (en) Method for treating cellulosic shaped bodies
GB2345063B (en) Method
GB9721603D0 (en) Method
GB9706282D0 (en) Method
GB9700320D0 (en) Method
IL134363A0 (en) Method for treating disease-related or drug-induced dyskinesias
IL125031A0 (en) Method for treating depression
AU2430999A (en) Method for treating various products and installation therefor
AU7107998A (en) Method for treating schizophrenia
GB9707744D0 (en) Method
AU6760298A (en) Method for treating hypertension
GB9717652D0 (en) Method
GB9714841D0 (en) Treatment method
AU2003201324A1 (en) Method for treating disease related or drug-induced dyskinesias
AU6896098A (en) Method for treating schizophrenia
HU0500389D0 (en) Method for treating dyskinesias
AU8560998A (en) Method for treating pcb-containing waste oil
GB9709811D0 (en) Method
GB9719212D0 (en) Anti-counterfeiting method
GB9711214D0 (en) Screening method
HU9701102D0 (en) Method for forming burial-grounds
GB9703102D0 (en) Treatment method
GB9701894D0 (en) Method